ACTIVE

Eastman Chemical Technology

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result115,5 k €+123,5 %over 1 year
Gross margin6,9 M €+19,4 %over 1 year
Equity616,9 k €+23,0 %over 1 year
Workforce50,2 ETP+5,0 %over 1 year

Identity

Source · BCE/KBO

Eastman Chemical Technology is a Private limited company incorporated in 2017. Its main activity is: Wholesale of chemical products. Its registered office is in Gent. It employs on average 50,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0671.793.393
Incorporation
23/02/2017
Legal form
Private limited company
Registered office
Technologiepark-Zwijnaarde 30
9052 Gent · FlandreSee on map
Contributed capital
20 000,00 €
Latest accounts
31/12/2025
Average workforce
50,2 ETP
Joint committees (1)
  • 207
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 8 filings

Trend over 8 financial years

20252024202320222021
Income statement
Gross margin6,9 M €5,8 M €5,3 M €4,9 M €4,3 M €
EBITDA936,1 k €653 k €597,2 k €923,2 k €742,6 k €
Operating result428,1 k €221,9 k €184,9 k €381,4 k €176 k €
Net result115,5 k €51,7 k €-34,4 k €272,7 k €64,2 k €
Balance sheet
Equity616,9 k €501,3 k €449,7 k €484 k €211,3 k €
Total assets5,2 M €5,7 M €4,9 M €4,3 M €4,6 M €
Cash303,4 k €23,6 k €145,7 k €47,9 k €134 k €
Debts4,6 M €5,2 M €4,4 M €3,8 M €4,4 M €
Other
Workforce50,2 ETP47,8 ETP46,3 ETP39,4 ETP31,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 4 ended

Active mandates

Joris Kuijpers

Director · since 01 juillet 2019

Active
Sabine Ketsman

Director · since 23 février 2017

Active

Ended mandates

Joris Kuijpers

Administrator - manager · since 01 juillet 2019

Ended
Erwin Dijkman

Manager · since 01 avril 2018 · until 30 juin 2019

Ended
Murray Deal

Manager · since 23 février 2017 · until 31 mars 2018

Ended
Sabine Ketsman

Manager · since 23 février 2017

Ended

Other companies at this address

Technologiepark-Zwijnaarde 30 9052 Gent
CompanyCBE no.
Confo Therapeutics● Active
0632.474.939
DEVGEN● Active
0461.432.562
Syngenta Seeds● Active
0404.599.569

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date25/06/202624/06/202521/06/202419/06/202321/06/202218/06/2021
General meeting11/06/202612/06/202513/06/202408/06/202309/06/202210/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 8 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202511/06/202625/06/2026DutchPDF
Abridged model31/12/202412/06/202524/06/2025DutchPDF
Abridged model31/12/202313/06/202421/06/2024DutchPDF
Abridged model31/12/202208/06/202319/06/2023DutchPDF
Abridged model31/12/202109/06/202221/06/2022DutchPDF
Abridged model31/12/202010/06/202118/06/2021DutchPDF
Abridged model31/12/201911/06/202022/06/2020DutchPDF
Abridged model31/12/201804/10/201908/10/2019DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 4 ended

Active mandates

Joris Kuijpers

Director · since 01 juillet 2019

Active
Sabine Ketsman

Director · since 23 février 2017

Active

Ended mandates

Joris Kuijpers

Administrator - manager · since 01 juillet 2019

Ended
Erwin Dijkman

Manager · since 01 avril 2018 · until 30 juin 2019

Ended
Murray Deal

Manager · since 23 février 2017 · until 31 mars 2018

Ended
Sabine Ketsman

Manager · since 23 février 2017

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Restructuring26/08/2026
    Neerlegging gezamenlijk fusievoorstel
    PDF
  • Mandates23/01/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office09/10/2024
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates27/01/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/03/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/03/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/06/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates11/04/2018
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025115,5 k €↑
  2. 2024
    Annual accounts 202451,7 k €↑
  3. 2023
    Annual accounts 2023-34,4 k €↓
  4. 2022
    Annual accounts 2022272,7 k €↑
  5. 2021
    Annual accounts 202164,2 k €↑
  6. 2020
    Annual accounts 202036,5 k €↓
  7. 2019
    Annual accounts 201954,2 k €↑
  8. 2018
    Annual accounts 201836,5 k €
  9. 23/02/2017
    IncorporationPrivate limited company